Effects of linoleic acid supplements on atopic dermatitis.
Giménez-Arnau
A
A
Department of Dermatology, Hospital del Mar, IMIM, Universitat Autònoma de Barcelona, Spain.
Barranco
C
C
Alberola
M
M
Wale
C
C
Serrano
S
S
Buchanan
M R
MR
Camarasa
J G
JG
D000328:Adult; D003876:Dermatitis, Atopic / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D019587:Dietary Supplements; D004311:Double-Blind Method; D004485:Eczema / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D004817:Epidermis / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000378:metabolism; D019787:Linoleic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D008041:Linoleic Acids / Q000378:metabolism; D008297:Male; D010865:Pilot Projects; D010919:Placebos; D012867:Skin / Q000187:drug effects / Q000378:metabolism / Q000473:pathology
D015525:Fatty Acids, Omega-3; D043371:Fatty Acids, Omega-6; D005231:Fatty Acids, Unsaturated; D006893:Hydroxyeicosatetraenoic Acids; D008041:Linoleic Acids; D010919:Placebos; C024348:13-hydroxy-9,11-octadecadienoic acid; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid; D019787:Linoleic Acid